Literature DB >> 30818999

Different morphological and gene expression profile in placentas of the same sickle cell anemia patient in pregnancies of opposite outcomes.

Letícia C Baptista1,2, Camilla O Figueira3,2, Bruno B Souza1, Kleber Y Fertrin4, Arthur Antolini5, Fernando F Costa6, Mônica B de Melo1,2, Maria Laura Costa3,2.   

Abstract

IMPACT STATEMENT: Environmentally induced changes in placental morphological and molecular phenotypes may provide relevant insight towards pathophysiology of diseases. The rare opportunity to evaluate the same patient, with sickle cell anemia (SCA), in two different pregnancies, of opposite outcomes (one early onset severe preeclampsia (PE) and the other mostly non-complicated) can prove such concept. In addition, the comparison to other conditions of known placental and vascular/inflammatory involvement strengthens such findings. Our results suggest that the clinical association between SCA and PE can be supported by common pathophysiological mechanisms, but that pathways involving response to copper and triglyceride metabolism may be important drivers of the pathophysiology of PE. Future studies using in a larger number of samples should confirm these findings and explore pathways involved in the pathophysiology of PE and its relationship with SCA.

Entities:  

Keywords:  Placenta; and pregnancy; gene expression; preeclampsia; sickle cell disease

Mesh:

Year:  2019        PMID: 30818999      PMCID: PMC6488870          DOI: 10.1177/1535370219834305

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  46 in total

Review 1.  The emerging understanding of sickle cell disease.

Authors:  G R Serjeant
Journal:  Br J Haematol       Date:  2001-01       Impact factor: 6.998

2.  ACOG Practice Bulletin No. 78: hemoglobinopathies in pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2007-01       Impact factor: 7.661

3.  The placental-umbilical unit in sickle cell disease pregnancy: a model for studying in vivo functional adjustments to hypoxia in humans.

Authors:  Paul Trampont; Martine Roudier; Anne-Marie Andrea; Nelly Nomal; Therese-Marie Mignot; Yanick Leborgne-Samuel; Sylvie Ravion; John Clayton; Didier Mary; Jacques Elion; Monique Decastel
Journal:  Hum Pathol       Date:  2004-11       Impact factor: 3.466

4.  Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies.

Authors:  Luís Belo; Muriel Caslake; Dairena Gaffney; Alice Santos-Silva; Luís Pereira-Leite; Alexandre Quintanilha; Irene Rebelo
Journal:  Atherosclerosis       Date:  2002-06       Impact factor: 5.162

5.  A novel model of polyhydramnios: amniotic fluid volume is increased in aquaporin 1 knockout mice.

Authors:  Stephanie E Mann; Emily A Ricke; Elvina A Torres; Robert N Taylor
Journal:  Am J Obstet Gynecol       Date:  2005-06       Impact factor: 8.661

6.  Pregnancy-specific glycoprotein gene expression in recurrent aborters: a potential correlation to interleukin-10 expression.

Authors:  L L Arnold; T M Doherty; A W Flor; J A Simon; J Y Chou; W Y Chan; B C Mansfield
Journal:  Am J Reprod Immunol       Date:  1999-03       Impact factor: 3.886

7.  [Expression and significance of aquaporin 1 in placenta, placental membranes and peritoneum of patients with hypertensive disorder complicating pregnancy].

Authors:  Liu-xia Li; Yue-ling Liu; Jian-guo Wen; Zhen-zhen Li; Yan-ping Zhao
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2008-07

8.  Morbidity associated with sickle cell disease in pregnancy.

Authors:  Margaret S Villers; Margaret G Jamison; Laura M De Castro; Andra H James
Journal:  Am J Obstet Gynecol       Date:  2008-06-04       Impact factor: 8.661

9.  Nutritional deficiencies in iron overloaded patients with hemoglobinopathies.

Authors:  Susan Claster; John C Wood; Leila Noetzli; Susan M Carson; Thomas C Hofstra; Rachna Khanna; Thomas D Coates
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

Review 10.  The placenta and intrauterine programming.

Authors:  A L Fowden; A J Forhead; P M Coan; G J Burton
Journal:  J Neuroendocrinol       Date:  2008-02-08       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.